Tergus Pharma Constructs cGMP Commercial Manufacturing Facility

Published 7-16-2019
  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park
  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park
  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park
  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park

    Courtesy of Tergus Pharma.

  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park

    Courtesy of Tergus Pharma.

  • Tergus Pharma - cGMP Commercial Manufacturing Facility - Research Triangle Park

    Courtesy of Tergus Pharma.

Tergus Pharma began construction in July of 2019 on a cGMP commercial manufacturing facility in Research Triangle Park in North Carolina. An existing 100,000-sf building will undergo renovation to become the company's headquarters, providing production suites, laboratories, offices, packaging lines, and a GMP warehouse. The $35 million project will also include a clinical trial materials manufacturing space and suites for the creation of high-potency compounds and hormones. Completion is expected in early 2020.